Liver Transplantation for Metastatic Neuroendocrine Tumors
- 1 October 2014
- journal article
- review article
- Published by Taylor & Francis in Hepatic Oncology
- Vol. 1 (4) , 409-421
Abstract
SUMMARY Neuroendocrine tumors are a heterogeneous group of rare epithelial tumors. Most of them are metastatic at the time of initial diagnosis. Liver transplantation (LT) has been proposed in selected patients with diffuse liver involvement. Rationale for LT in this indication is based on the frequently indolent nature of neuroendocrine tumors, the propensity for liver-only metastasis and the high rate of intrahepatic recurrence after resection. However, indications for LT for neuroendocrine liver metastases remain controversial, and patient selection criteria is still a matter of debate. The aim of this review is to summarize data regarding LT for neuroendocrine liver metastases by answering frequently asked questions about this issue.Keywords
This publication has 39 references indexed in Scilit:
- Emerging Approaches in the Management of Patients with Neuroendocrine Liver Metastasis: Role of Liver-Directed and Systemic TherapiesJournal of the American College of Surgeons, 2013
- Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the LiverAmerican Journal of Surgical Pathology, 2011
- Liver Transplantation for Hepatic Metastases of Neuroendocrine Pancreatic Tumors: A Survival-Based AnalysisTransplantation, 2011
- Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: The US ExperienceInternational Journal of Hepatology, 2011
- Oral abstractsAmerican Journal of Transplantation, 2010
- Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?Surgery, 2009
- Predictors of Long-Term Survival After Liver Transplantation for Metastatic Endocrine Tumors: An 85-Case French Multicentric ReportAmerican Journal of Transplantation, 2008
- Liver transplantation for neuroendocrine tumorsJournal of Gastrointestinal Surgery, 2004
- Ki67, E-CADHERIN, AND p53 AS PROGNOSTIC INDICATORS OF LONG-TERM OUTCOME AFTER LIVER TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE TUMORSTransplantation, 2002
- Orthotopic liver transplantation in the treatment of metastatic neuroendocrine tumors of the liverLiver Transplantation and Surgery, 1995